Aldeyra Therapeutics, Inc.
USD1.64
-0.02 (-1.20%)
CEO
Todd C. Brady
IPO Date
2014-05-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.65
Prev. Close
$1.66
Day Low
$1.58
Day High
$1.69
52W Low
$1.07
52W High
$6.17
Market Cap
$0.10B
Volume
0.88M
| 632,318 |
| $0.00 |
| 20 Mar 2026 | DOUGLAS RICHARD | director | P-Purchase | Acquired | 70,000 | $1.40 |
| 19 Mar 2026 | Alfieri Michael | Principal Financial Officer | P-Purchase | Acquired | 5,000 | $1.42 |
| 15 Aug 2025 | Alfieri Michael | Principal Financial Officer | P-Purchase | Acquired | 2,500 | $5.30 |
| 13 Aug 2025 | Machatha Stephen | Chief Development Officer | S-Sale | Disposed | 22,073 | $5.15 |
| 12 Jun 2025 | Walker Neal | director | A-Award | Acquired | 62,728 | $2.69 |
| 12 Jun 2025 | Walker Neal | director | A-Award | Acquired | 2,413 | $2.69 |
| 12 Jun 2025 | Miller-Rich Nancy | director | A-Award | Acquired | 62,728 | $2.69 |
| 12 Jun 2025 | Miller-Rich Nancy | director | A-Award | Acquired | 2,413 | $2.69 |